Home/4D Path/Anna Berry, MD

AB

Anna Berry, MD

Consultant Pathologist

Therapeutic Areas

4D Path Pipeline

Drug	Indication	Phase
QPOR Platform for Breast Cancer	Breast Cancer	Breakthrough Device Designation
QPOR Platform for Immunotherapy Response	Advanced Metastatic Melanoma	Clinical Study

Leadership Team at 4D Path

Jacopo Leonardi

Chief Executive Officer

Satabhisa Mukhopadhyay, PhD

Founder, Chief Scientific Officer

Tathagata Dasgupta, PhD

Founder, President & Chief Technology Officer

Nicholas Bero, JD

Chief Operating Officer & Chief Legal Officer

View full 4D Path profile